Immune-based Combinations in Intermediate-/Poor-risk Patients with Non-clear Cell Renal Cell Carcinoma: Results from the ARON-1 Study.

Saved in:
Bibliographic Details
Title: Immune-based Combinations in Intermediate-/Poor-risk Patients with Non-clear Cell Renal Cell Carcinoma: Results from the ARON-1 Study.
Authors: Massari F; Medical Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy; Department of Medical and Surgical Sciences (DIMEC), University of Bologna, Bologna, Italy., Mollica V; Medical Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy. Electronic address: veronica.mollica7@gmail.com., Kopp RM; Clinical oncology, Sociedad de Oncología y Hematología del Cesar, Valledupar, Colombia., Grande E; Department of Medical Oncology, MD Anderson Cancer Center Madrid, Madrid, Spain., Fiala O; Department of Oncology and Radiotherapeutics, Faculty of Medicine, University Hospital in Pilsen, Charles University, Pilsen, Czech Republic; Biomedical Center, Faculty of Medicine in Pilsen, Charles University, Pilsen, Czech Republic., Kanesvaran R; Division of Medical Oncology, National Cancer Centre Singapore, Singapore., Li H; Division of Medical Oncology, Department of Internal Medicine, University of Kansas Cancer Center, Westwood, KS, USA., Schieber TJ; Division of Medical Oncology, Department of Internal Medicine, University of Kansas Cancer Center, Westwood, KS, USA., Juan Fita MJ; Medical Oncology, Fundación Instituto Valenciano de Oncología, Valencia, Spain., Poprach A; Masaryk Memorial Cancer Institute, Brno, Czech Republic; Faculty of Medicine, Masaryk University, Brno, Czech Republic., Lolli C; Department of Medical Oncology, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori', Meldola, Italy., Bourlon MT; Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico., de Liaño AG; Medical Oncology Department, CHU Insular-Materno Infantil, Las Palmas, Spain., Grillone F; Medical Oncology Unit, Presidio Ospedaliero Pugliese Ciaccio, Azienda Ospedaliera Universitaria 'Renato Dulbecco', Catanzaro, Italy., Sunela K; Department of Oncology, Tampere Cancer Center, Faculty of Medicine and Health Technology, Tampere University Hospital, Tampere University, Tampere, Finland., Rizzo A; S.S.D. C.O.r.O. Bed Management Presa in Carico, TDM, IRCCS Istituto Tumori 'Giovanni Paolo II', Bari, Italy., Ghosn M; Hematology-Oncology Department, Faculty of Medicine, Saint Joseph University of Beirut, Beirut, Lebanon., Cerbone L; Department of Medical Oncology, San Camillo Forlanini Hospital, Rome, Italy., Taha T; The Institute of Cancer Research, London, UK; The Royal Marsden NHS Foundation Trust, London, UK., Ürün Y; Medical Oncology, Ankara University Medical Faculty, Ankara, Turkey., Molina-Cerrillo J; Medical Oncology Department, Hospital Universitario Ramón y Cajal, Madrid, Spain., Alonso-Gordoa T; Medical Oncology Department, Hospital Universitario Ramón y Cajal, Madrid, Spain., Lenci E; Medical Oncology Unit, Azienda Ospedaliera Ospedali Riuniti Marche Nord, Pesaro, Italy., Martin IO; Department of Medical Oncology, MD Anderson Cancer Center Madrid, Madrid, Spain., Abu-Sini H; Oncology Institute, Rambam Healthcare campus, Haifa, Israel., Rescigno P; Translational and Clinical Research Institute, Centre for Cancer, Newcastle University, Newcastle upon Tyne, UK., Bhuva D; Department of Medical Oncology, Army Hospital Research and Referral, New Delhi, India., Fay AP; PUCRS School of Medicine, Porto Alegre, RS, Brazil., Conteduca V; Unit of Medical Oncology and Biomolecular Therapy, Department of Medical and Surgical Sciences, University of Foggia, Policlinico Riuniti, Foggia, Italy., Yildirim A; Department of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, GA, USA., Rosellini M; Medical Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy; Department of Medical and Surgical Sciences (DIMEC), University of Bologna, Bologna, Italy., Akova U; Department of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, GA, USA., Tassinari E; Medical Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy; Department of Medical and Surgical Sciences (DIMEC), University of Bologna, Bologna, Italy., Bölek H; Medical Oncology, Ankara University Medical Faculty, Ankara, Turkey., Soares A; Latin American Cooperative Oncology Group - LACOG, Porto Alegre, Brazil; Hospital Israelita Albert Einstein, São Paulo, SP, Brazil., Marques Monteiro FS; Latin American Cooperative Oncology Group - LACOG, Porto Alegre, Brazil; Hospital Sírio-Libanês, Brasília, DF, Brazil., Buti S; Medical Oncology Unit, University Hospital of Parma, Parma, Italy; Department of Medicine and Surgery, University of Parma, Parma, Italy., Bilen MA; Department of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, GA, USA; Winship Cancer Institute of Emory University, Atlanta, GA, USA., Santoni M; Medical Oncology Unit, Macerata Hospital, Macerata, Italy.
Source: European urology focus [Eur Urol Focus] 2025 Sep; Vol. 11 (5), pp. 736-746. Date of Electronic Publication: 2025 Jul 29.
Publication Type: Journal Article; Multicenter Study
Journal Info: Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101665661 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2405-4569 (Electronic) Linking ISSN: 24054569 NLM ISO Abbreviation: Eur Urol Focus Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2405-4569
DOI:10.1016/j.euf.2025.05.020